JACK GOLDSTEIN Insider Trading $ACHV ACHIEVE LIFE SCIENCES, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JACK GOLDSTEIN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JACK GOLDSTEIN. JACK GOLDSTEIN is President & Chief Operating Of in CHIRON CORP ($CHIR) and V.P., Chief Operating Officer in CHIRON CORP ($CHIR) and V.P.; Pres., Chiron Blood Test in CHIRON CORP ($CHIR) and Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and Director in ACCURAY INC ($ARAY).

JACK GOLDSTEIN in ACHIEVE LIFE SCIENCES, INC.

Trading Symbol: ACHV
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of JACK GOLDSTEIN: Director
Holdings: 17,500 shares
Current Value: $10,500
Latest Transaction: May 27 2016
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JACK GOLDSTEIN in ACHIEVE LIFE SCIENCES, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARAY, ACHV, CHIR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 27 2016OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorOption ExerciseA1.0031,50031,50031,500
May 24 2016OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorOption ExerciseM0.005,00000
May 24 2016OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorBuyM0.005,000017,50012.5 K to 17.5 K (+40.00 %)
May 22 2015OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorOption ExerciseA0.005,00005,000
May 22 2015OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorOption ExerciseA1.895,0009,4505,000
May 22 2015OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorOption ExerciseM0.005,00000
May 22 2015OGXIONCOGENEX PHARMACE ...GOLDSTEIN JACKDirectorBuyM0.005,000012,5007.5 K to 12.5 K (+66.67 %)

Page:   1